London, UK (PRWEB) March 07, 2014 During the last 20 years, the ongoing genetic advances have considerably facilitated the emergence of personalized medicine sector as an important player in the overall healthcare universe. Human genome sequencing has propelled the pharmacogenetics sector. Furthermore, personalized medicine also takes into account pharmacogenomics studies, where protein and genetic interactions yield the potential drug targets. The key objective of personalized medicine is to offer individualized care that is more effective and specific to the potential patients. Targeted and personalized medicine R&D efforts are aimed at increasing the efficiency of the therapeutic area via genetic testing along with companion diagnostics. The introduction of novel personalized medicine will likely reduce the frequency of adverse drug reactions and thus have a significant influence on health economics. Diagnostic and developmental companies are predicted to take benefit from lower discovery and commercialization costs, as well as from more specific market sub-types awaited in the years ahead. Nodality, Celera, 23andMe, Myriad, Amgen, Atossa Genetics and Affymetrix are among the leading participants in the worldwide market for personalized medicine and companion diagnostic tests. New research report Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and … Continue reading →

It cost over $3 billion and took almost 13 years to sequence the human genome for the first time, a task that was only completed a little over ten years ago. Instead of our current one-size-fits all treatment for most diseases, many envision a future in which we will be able to tailor medical treatment based on ones underlying genetic information, a medical model known as personalized, or precision, medicine. To better understand what it will take to reach these aims, which will require further advances in many disciplines and have implications stretching far beyond the field of medicine, University President Lee Bollinger recently announced the creation of a task force on personalized medicine. When there are major advances in our knowledge that can be translated in very important effects for the world, we want to make sure as the university we are doing everything we can to facilitate that, Bollinger said at last weeks University Senate plenary. The task force, co-chaired by Provost John Coatsworth and Dean of the Faculties of Health Sciences and Medicine Lee Goldman, brings together almost 40 faculty members across the entire university. Unlike other institutions, including various cancer centers, that are also working in … Continue reading →

Knee Replacement vs. Stem Cell Therapy - Regenexx Hundreds of thousands undergo knee replacement each year, but the outcomes are often not what people expect. The Regenexx-SD same day stem cell procedure off... By: Regenexx … Continue reading →

Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans. Recent developments in stem cell research have made it possible to assess its effect on intervertebral disc (IVD) height, Mayo Clinic researchers reported in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine. "This landmark study draws the conclusion in pre-clinical animal studies that stem cell therapy for disc degenerative disease might be a potentially effective treatment for the very common condition that affects people's quality of life and productivity," said the senior author, Wenchun Qu, MD, PhD, of the Mayo Clinic in Rochester, Minn. Dr. Qu said not only did disc height increase, but stem cell transplant also increased disc water content and improved appropriate gene expression. "These exciting developments place us in a position to prepare for translation of stem cell therapy for degenerative disc disease into clinical trials," he said. The increase in disc height was due to restoration in the transplant group of the nucleus pulposus structure, which refers to the jelly-like substance in the disc, … Continue reading →

nanomedicine nanobiotix itele By: Laurent L … Continue reading →